| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the University Department of Clinical Neurology, Radcliffe Infirmary, Oxford, UK.
Address correspondence and reprint requests to Prof Rothwell, University Department of Clinical Neurology, Radcliffe Infirmary, Oxford, UK OX2 6HE; e-mail: peter.rothwell{at}clinical-neurology.ox.ac.uk
Background: Benefit from carotid endarterectomy is greatest when performed within 2 weeks of a presenting TIA or stroke and decreases rapidly thereafter.
Objective: To determine the delays to carotid imaging and endarterectomy in Oxfordshire, UK, and the consequences for the effectiveness of stroke prevention.
Methods: All patients undergoing carotid imaging for ischemic retinal or cerebral TIA or stroke were identified in two populations: the population of Oxfordshire, UK (n = 680,772), from April 1, 2002, to March 31, 2003, and the Oxford Vascular Study (OXVASC) subpopulation (n = 92,000) from April 1, 2002, to March 31, 2004. The times from presenting event to referral, scanning, and endarterectomy (Oxfordshire population) and the risk of stroke prior to endarterectomy in patients with 
50% symptomatic carotid stenosis (OXVASC population) were determined.
Results: Among 853 patients who had carotid imaging in the Oxfordshire population, median (interquartile range) times from presenting event to referral, scanning, and endarterectomy were 9 (3 to 30), 33 (12 to 62), and 100 (59 to 137) days. Eighty-five patients were found to have 50 to 99% symptomatic stenosis, of whom 49 had endarterectomy. Only 3 (6%) had surgery within 2 weeks of their presenting event and only 21 (43%) within 12 weeks. The risk of stroke prior to endarterectomy in the OXVASC subpopulation with 50% stenosis was 21% (8 to 34%) at 2 weeks and 32% (17 to 47%) at 12 weeks, in half of which strokes were disabling or fatal.
Conclusion: Delays to carotid imaging and endarterectomy after TIA or stroke in the United Kingdom are similar to those reported in several other countries and are associated with very high risks of otherwise preventable early recurrent stroke.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the August 9 issue to find the title link for this article.
This article was previously published in electronic format as an Expedited E-Pub on July 14, 2005, at www.neurology.org.
Disclosure: The authors report no conflicts of interest.
Received February 25, 2005. Accepted in final form April 25, 2005.
This article has been cited by other articles:
|
|
 |
|
  A. Ois, M. Gomis, A. Rodriguez-Campello, E. Cuadrado-Godia, J. Jimenez-Conde, C. Pont-Sunyer, G. Cuccurella, and J. Roquer Factors Associated With a High Risk of Recurrence in Patients With Transient Ischemic Attack or Minor Stroke Stroke, June 1, 2008; 39(6): 1717 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Golledge Response to Letter by Tang et al Stroke, December 1, 2007; 38(12): e158 - e159. [Full Text] [PDF]
|
|
|
|
|
|
J. Golledge Asymptomatic Carotid Stenosis Stroke, November 1, 2007; 38(11): e150 - e150. [Full Text] [PDF]
|
|
|
|
 |
|
 P. M Rothwell Transient ischaemic attacks: time to wake up Heart, August 1, 2007; 93(8): 893 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kastrup, K. Groschel, and U. Ernemann Response to Letter by Cohen Stroke, May 1, 2007; 38(5): e19 - e20. [Full Text] [PDF]
|
|
|
|
|
|
J. Golledge, S. Mangan, and P. Clancy Effects of Peroxisome Proliferator-Activated Receptor Ligands in Modulating Tissue Factor and Tissue Factor Pathway Inhibitor in Acutely Symptomatic Carotid Atheromas Stroke, May 1, 2007; 38(5): 1501 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Altaf, S. T. MacSweeney, J. Gladman, and D. P. Auer Carotid Intraplaque Hemorrhage Predicts Recurrent Symptoms in Patients With High-Grade Carotid Stenosis Stroke, May 1, 2007; 38(5): 1633 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N.E. Redgrave, S. B. Coutts, U. G. Schulz, D. Briley, and P. M. Rothwell Systematic Review of Associations Between the Presence of Acute Ischemic Lesions on Diffusion-Weighted Imaging and Clinical Predictors of Early Stroke Risk After Transient Ischemic Attack Stroke, May 1, 2007; 38(5): 1482 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P M Rothwell Atherothrombosis and ischaemic stroke BMJ, February 24, 2007; 334(7590): 379 - 380. [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein and P. M. Rothwell Primary Prevention and Health Services Delivery Stroke, February 1, 2007; 38(2): 222 - 224. [Full Text] [PDF]
|
|
|
|
|
|
A. Kastrup, U. Ernemann, T. Nagele, and K. Groschel Risk Factors for Early Recurrent Cerebral Ischemia Before Treatment of Symptomatic Carotid Stenosis Stroke, December 1, 2006; 37(12): 3032 - 3034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tsivgoulis, K. Spengos, P. Manta, N. Karandreas, T. Zambelis, N. Zakopoulos, and D. Vassilopoulos Validation of the ABCD Score in Identifying Individuals at High Early Risk of Stroke After a Transient Ischemic Attack: A Hospital-Based Case Series Study Stroke, December 1, 2006; 37(12): 2892 - 2897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F Fairhead and P. M Rothwell Underinvestigation and undertreatment of carotid disease in elderly patients with transient ischaemic attack and stroke: comparative population based study BMJ, September 9, 2006; 333(7567): 525 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.N.E. Redgrave, J.K. Lovett, P.J. Gallagher, and P.M. Rothwell Histological Assessment of 526 Symptomatic Carotid Plaques in Relation to the Nature and Timing of Ischemic Symptoms: The Oxford Plaque Study Circulation, May 16, 2006; 113(19): 2320 - 2328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Rothwell and S. C. Johnston Transient Ischemic Attacks: Stratifying Risk Stroke, February 1, 2006; 37(2): 320 - 322. [Full Text] [PDF]
|
|
|
|
|
|
Minerva BMJ, December 17, 2005; 331(7530): E398 - E398. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
